Peptide Library

FDA-approved

Sexual & reproductive

Goserelin

Evidence

FDA approved

Class

GnRH agonist

/

Goserelin

KEY TAKEAWAY

Goserelin is a synthetic GnRH agonist delivered as a small implant. It is sold as Zoladex. The FDA approved goserelin (Zoladex) in 1989, and it is now approved for several hormone-sensitive cancers and gynecologic conditions.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

GnRH agonist

Approved for

Prostate cancer, breast cancer, endometriosis and uterine fibroids

Key fact

The FDA approved goserelin (Zoladex) in 1989, and it is now approved for several hormone-sensitive cancers and gynecologic conditions.

Route

Implant under the skin of the abdomen every 1 to 3 months

Evidence strength

FDA approved

What it is

What it is

Goserelin is a synthetic GnRH agonist delivered as a small implant. It is sold as Zoladex.

How it works

How it works

It first stimulates and then desensitizes GnRH receptors, which lowers sex hormone production over time.

Regulatory status

Regulatory status

The FDA approved goserelin (Zoladex) in 1989, and it is now approved for several hormone-sensitive cancers and gynecologic conditions.

What it is used for

What it is used for

Prostate cancer, breast cancer, endometriosis and uterine fibroids.

Side effects and risks

Side effects and risks

Hot flashes, reduced libido and bone density loss are common. Hormone levels can briefly rise at the start of treatment.

Citations

Citations

U.S. FDA prescribing information for Goserelin. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo